1-20 of 24
Ye Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TP53 Mutations Distinguish a Class of Highly Homogenous Myeloid Neoplasms within MDS and AML in the Context of Complex Karyotype

Hongyan Tong, Ye Yang, Lingxu Jiang, Xinping Zhou, Liya Ma, Gaixiang Xu, Yudi Zhang, Wei Wang, Xiaozhen Liu, Huchu Yu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6712.
https://doi.org/10.1182/blood-2024-207477
Published: 2024
Journal Articles

Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study

Li Ye, Ye Yang, Xuewu Zhang, Lu Wang, Li Zhu, Xia Li, Yile Zhou, Xiaolong Zheng, Xinping Zhou, Yanling Ren, Liya Ma, Gaixiang Xu, Chunmei Yang, Huafeng Wang, De Zhou, Min Yang, Xingnong Ye, Juying Wei, Wen-Juan Yu, Jiejing Qian, Yinjun Lou, Wanzhuo Xie, Jian Huang, Haitao Meng, Jie Jin, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 5384.
https://doi.org/10.1182/blood-2023-184470
Published: 2023
Journal Articles

CHEK1 and circCHEK1_246aa Promote Multiple Myeloma Malignancy By Evoking Chromosomal Instability and Bone Lesion

Ye Yang, PhD, Chunyan Gu, Wang Wang, Xiaozhu Tang
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-134206
Published: 2020
Journal Articles

RFWD2 Induces Cellular Proliferation and Proteasome Inhibitor Resistance By Mediating p27 Ubiqutinaiton in Multiple Myeloma

Ye Yang, PhD, Mengjie Guo, Chunyan Gu
Journal: Blood
Blood (2019) 134 (Supplement_1): 3068.
https://doi.org/10.1182/blood-2019-127888
Published: 2019
Journal Articles

Targeting NEK2 Induces Cellular Senescence in B-Cell Malignancies through p53-Independent Signaling Pathways

Yuqi Zhu, Ye Yang, PhD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Ivana Frech, DSc, PhD MBA, Guido J. Tricot, MD PhD, Fenghuang Zhan, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3102.
https://doi.org/10.1182/blood-2019-123815
Published: 2019
Journal Articles

Coexistence of a Huge Venous Thromboembolism and Bleeding Tendency in Cytokine Release Syndrome during CAR-T Therapy

Haiyan Liu, MD, Ye Yang, PhD, Hongming Huang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5590.
https://doi.org/10.1182/blood-2019-129389
Published: 2019
Journal Articles

The Efficacy of a Novel Oral Proteasome Inhibitor NNU546 in Multiple Myeloma

Ye Yang, PhD, Yongqiang Zhu, Chunyan Gu
Journal: Blood
Blood (2019) 134 (Supplement_1): 5586.
https://doi.org/10.1182/blood-2019-127927
Published: 2019
Journal Articles

MK2 Is a Therapeutic Target for High-Risk Multiple Myeloma

Chunyan Gu, PhD, Hongbao Yang, Hailin Peng, Zhiye Xu, Ruini Chen, PhD, Ye Yang, PhD
Journal: Blood
Blood (2016) 128 (22): 5612.
https://doi.org/10.1182/blood.V128.22.5612.5612
Published: 2016
Journal Articles

FOXM1, CDK6 and Rb Dependent Drug Resistance and Senescence in Myeloma

Chunyan Gu, PhD, Ruini Chen, PhD, Xuefang Jing, PhD, Siegfried Janz, Ye Yang, PhD
Journal: Blood
Blood (2016) 128 (22): 4456.
https://doi.org/10.1182/blood.V128.22.4456.4456
Published: 2016
Journal Articles

Targeting Neddylation to Overcome Drug Resistance in Multiple Myeloma

Gregory S Thomas, PhD, Junwei Huang, MD, Yi Zhou, PhD, Zhimin Gu, PhD, Ye Yang, PhD, Hongwei Xu, Guido J Tricot, MD PhD, Fenghuang Zhan, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1804.
https://doi.org/10.1182/blood.V126.23.1804.1804
Published: 2015
Journal Articles

Decreased FPN1 in Myeloma Promotes Malignant Cell Growth and Osteoclast Differentiation

Zhimin Gu, PhD, He Wang, PhD, Jiliang Xia, MS, Ivana De Domenico, PhD, Ye Yang, PhD, Junwei Huang, MD, Hongwei Xu, DDS, Zhengdong Jin, PhD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2017.
https://doi.org/10.1182/blood.V124.21.2017.2017
Published: 2014
Journal Articles

NEK2 Suppresses Cellular Senescence through Regulation of the β-Catenin/CCND2/RB Axis in Multiple Myeloma

Ye Yang, PhD, Guido J. Tricot, MD, PhD, Xia Jiliang, Zhimin Gu, PhD, Hongwei Xu, DDS, Mu Hao, PhD, Fenghuang Zhan, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2024.
https://doi.org/10.1182/blood.V124.21.2024.2024
Published: 2014
Journal Articles

Hypermethylation of TAp73 Suppresses ABL1-Involved DNA Damage Response in Multiple Myeloma

Mu Hao, PhD, Yu Qin, PhD, Meirong Zang, PhD, Yan Xu, MD PhD, Gang An, MD PhD, Changhong Li, MD, Ye Yang, PhD, Zhimin Gu, PhD, Fenghuang Zhan, MD PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3374.
https://doi.org/10.1182/blood.V124.21.3374.3374
Published: 2014
Journal Articles

Elevated Expression Of CKS1B Inhibits Senescence Thorough Enhanced Degradation Of p21 In Multiple Myeloma

Zhimin Gu, PhD, Yi Zhou, PhD, He Wang, MD, Ye Yang, PhD, Hongwei Xu, DDS, Junwei Huang, MD, Jie He, MD, Yi Tao, MD&PhD, Guido J. Tricot, M.D., Ph.D., Fenghuang Zhan, MD&PhD
Journal: Blood
Blood (2013) 122 (21): 1882.
https://doi.org/10.1182/blood.V122.21.1882.1882
Published: 2013
Journal Articles

RARα2 Expression Confers Myeloma Stem Cell Features

Guido J. Tricot, M.D., Ph.D., Ye Yang, PhD, Zhimin Gu, PhD, Hongwei Xu, DDS, Junwei Huang, MD, Jie He, MD, Yi Tao, MD&PhD, Fenghuang Zhan, MD&PhD
Journal: Blood
Blood (2013) 122 (21): 5404.
https://doi.org/10.1182/blood.V122.21.5404.5404
Published: 2013
Journal Articles

High Trip13 and Low P31 Comet Cause Drug Resistance and Poor Prognosis In Multiple Myeloma

Yi Tao, MD&PhD, Zhimin Gu, PhD, Ye Yang, PhD, Hongwei Xu, DDS, Xiaojing Hu, Guido J. Tricot, M.D., Ph.D., Fenghuang Zhan, MD&PhD, Jumei Shi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3820.
https://doi.org/10.1182/blood.V122.21.3820.3820
Published: 2013
Journal Articles

Targeting BTK As a Treatment For Multiple Myeloma Stem Cells

Ye Yang, PhD, Zhimin Gu, PhD, Hongwei Xu, DDS, Junwei Huang, MD, Jie He, MD, Yi Tao, MD&PhD, Guido J. Tricot, M.D., Ph.D., Fenghuang Zhan, MD&PhD
Journal: Blood
Blood (2013) 122 (21): 271.
https://doi.org/10.1182/blood.V122.21.271.271
Published: 2013
Journal Articles

RARα2 expression confers myeloma stem cell features

Ye Yang, Jumei Shi, Giulia Tolomelli, Hongwei Xu, Jiliang Xia, He Wang, Wen Zhou, Yi Zhou, Satyabrata Das, Zhimin Gu, Dana Levasseur, Fenghuang Zhan, Guido Tricot
Journal: Blood
Blood (2013) 122 (8): 1437–1447.
https://doi.org/10.1182/blood-2013-02-482919
Published: 2013
Includes: Supplemental data
Journal Articles

Skeletal-Targeted, Osteolytic-Responsive Drug Delivery System Improves Anti-Tumor Efficacy in Multiple Myeloma.

Xuli Wang, PhD, Ye Yang, PhD, Scott Miller, PhD, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3155.
https://doi.org/10.1182/blood.V120.21.3155.3155
Published: 2012
Journal Articles

Phase I Exploratory Study of IV Formulation of Panobinostat in Combination with Bortezomib in Relapsed/Refractory Multiple Myeloma Patients: Effect On Serum PTH and Gene Expression Profiling (GEP) Studies

Maurizio Zangari, MD, Tamara Berno, MD, Giampaolo Talamo, MD, Xin Zhan, Wen Zhou, He Wang, Ye Yang, PhD, Jiliang Xia, Yi Zhou, Karen Pena, Leanne Lujan, Jessica Kohan, Mohamed E Salama, M.D., Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4073.
https://doi.org/10.1182/blood.V120.21.4073.4073
Published: 2012